Prashant Chittiboina

Neurosurgery

10 Center Dr Rm 3D20
Bethesda, MD 20892

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 121 publications

Germline NF2 variant position constrains somatic second hits and determines clinical severity in Neurofibromatosis Type 2-related schwannomatosis.

Germline NF2 variant position constrains somatic second hits and determines clinical severity in Neurofibromatosis Type 2-related schwannomatosis.

Journal: medRxiv : the preprint server for health sciences

Published: August 20, 2026

Neurogenetic tumor syndromes: The current landscape of workup and treatment.

Neurogenetic tumor syndromes: The current landscape of workup and treatment.

Journal: Neuro-oncology practice

Published: March 09, 2026

Phosphoproteomic dysregulation drives tumor proliferation in Cushing's disease.

Phosphoproteomic dysregulation drives tumor proliferation in Cushing's disease.

Journal: bioRxiv : the preprint server for biology

Published: December 31, 2025

Phosphoproteomic dysregulation drives tumor proliferation in Cushing's disease.

Phosphoproteomic dysregulation drives tumor proliferation in Cushing's disease.

Journal: bioRxiv : the preprint server for biology

Published: December 31, 2025

Variable Schwann cell merlin inactivation is targetable with TEAD1 inhibition in schwannomas.

Variable Schwann cell merlin inactivation is targetable with TEAD1 inhibition in schwannomas.

Journal: bioRxiv : the preprint server for biology

Published: November 26, 2025

Gadolinium-Enhanced Portable Ultra-Low-Field MRI for Evaluating Various Intracranial Pathologies.

Gadolinium-Enhanced Portable Ultra-Low-Field MRI for Evaluating Various Intracranial Pathologies.

Journal: AJNR. American journal of neuroradiology

Published: September 15, 2025

Intralabyrinthine MRI FLAIR as a predictive marker for hearing loss in vestibular schwannomas in Neurofibromatosis Type 2.

Intralabyrinthine MRI FLAIR as a predictive marker for hearing loss in vestibular schwannomas in Neurofibromatosis Type 2.

Journal: Journal of neuro-oncology

Published: August 14, 2025

Multigenerational VHL family characterized by pathogenic germline ELOC variant: Response to belzutifan.

Multigenerational VHL family characterized by pathogenic germline ELOC variant: Response to belzutifan.

Journal: Urologic oncology

Published: August 12, 2025

Radiological Surveillance for Pituitary Adenomas in Multiple Endocrine Neoplasia Type 1: A Longitudinal Cohort Study.

Radiological Surveillance for Pituitary Adenomas in Multiple Endocrine Neoplasia Type 1: A Longitudinal Cohort Study.

Journal: The Journal of clinical endocrinology and metabolism

Published: July 30, 2025

Genetic evaluation of pediatric pituitary adenomas and USP8-related genotype-phenotype correlations in Cushing's disease.

Genetic evaluation of pediatric pituitary adenomas and USP8-related genotype-phenotype correlations in Cushing's disease.

Journal: Pituitary

Published: July 07, 2025

Basilar artery vasospasm following transsphenoidal resection of recurrent pituitary macroadenoma: illustrative case.

Basilar artery vasospasm following transsphenoidal resection of recurrent pituitary macroadenoma: illustrative case.

Journal: Journal of neurosurgery. Case lessons

Published: June 12, 2025

Pathway-instructed therapeutic selection of ruxolitinib reduces neuroinflammation in fungal postinfectious inflammatory syndrome.

Pathway-instructed therapeutic selection of ruxolitinib reduces neuroinflammation in fungal postinfectious inflammatory syndrome.

Journal: Science advances

Published: March 21, 2025

Showing 1-12 of 121

Last Updated: 09/26/2026